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Introduction
The impact of glycosylation, one of the most important post-translational modifications, on the structure and biological properties of glycoproteins has been well documented [1, 2] . IgG molecules are mainly glycosylated at Asn-297 of the CH2 domain within the Fc region [3, 4] with variable galactosylation but limited sialylation. The remaining glycosylation occurs in the hypervariable regions of the Fab region, with position and frequency of occurrence dependent on the presence of the consensus sequence Asn-Xaa-Thr/Ser for N-glycosylation and is characterized by a high incidence of sialylated structures. Murine IgGs contain 2.3 asparagine-linked (N-linked) biantennary oligosaccharide chains per molecule [5] , and human IgGs, 2.8 [6] . The minimal oligosaccharide structure is a hexasaccharide (GlcNAc2Man3GlcNAc) with variable sugar residues attached, which results in the generation of the multiple glycoforms. About 30 variants of biantennary chains occur, resulting in many different glycoforms of IgG [6] . X-ray crystal electron density maps of the IgG-Fc revealed that the N297 linked glycan is sequestered within the internal space enclosed by the CH2 domains. There are extensive noncovalent interactions between the carbohydrate and the protein moiety, resulting in reciprocal influences on conformation [3] .
These complex biantennary-type oligosaccharides attached to IgG have been shown to be essential for effector functions mediated through Fc receptors (FcRs) and complement C1q [7, 8] . Furthermore, the Fc glycans of IgG are critically involved in the structural integrity of the antibody [9] [10] [11] . Modifications in these oligosaccharides affect susceptibility to proteolytic degradation, clearance rate, antibody-dependent cellular cytotoxicity (ADCC), as well as complement activation apart from binding to FcRs, monocytes, protein G and C1q/C1 [12] [13] [14] [15] [16] [17] . However, Fc-glycosylation is not required either for protein A binding [18] or recognition of antigen [19] [20] [21] [22] . Recently, de-fucosylation on the N297 -linked glycan in the Fc part of the Ab has been shown to increase ADCC activity indicating the importance of glyco-engineering of Abs for improved clinical efficacy [23] . On the other hand, Fab N-linked glycosylation in the hypervariable regions, while occurring much less frequently, has been reported to influence the binding affinity of antigens [24] [25] [26] and may also be involved in IgG self-association, aggregation, and cryo-precipitation [27] .
Glycoside hydrolases (EC 3.2.1.-) are a group of enzymes found in all types of organisms including bacteria and mammals, which hydrolyze the glycosidic bond between two or more carbohydrates or between a carbohydrate and a noncarbohydrate moiety. Earlier, we reported a novel secreted endo-β-Nacetylglucosaminidase, a member of the glycosyl hydrolases of family 18 (FGH18) in S. pyogenes (EndoS), which specifically hydrolyzes the β-1,4-di-N- 
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EndoS removes carbohydrate moieties from CII-specific mouse mAbs
EndoS specifically hydrolyzes the β-1,4-di-N-acetylchitobiose core of the N-linked glycan of IgG, which can be visualized by a size difference (4kDa) on SDS-PAGE and lectin blot analysis using Lens culinaris agglutinin (LCA) (Fig 1) . LCA recognizes sequences containing α-linked mannose residues and is enhanced in its affinity binding by the core fucose attached to the GlcNAc closest to the asparagine on the protein backbone. LCA lectin blot analysis of the samples revealed a significantly reduced signal when incubated with EndoS. Loss of lectin signal has previously been shown to correspond well to the complete digestion of the chitobiose core of the glycan on N297 of human γ-chains as determined by mass spectroscopy [38] . In contrast, the γ-chains were easily recognized by the LCA lectin when incubated in the absence of EndoS. These data support the hypothesis that EndoS has the ability to remove structures containing α-1,3 mannose from the γ-chains of mouse IgG.
EndoS-treated antibodies bind to cartilage in vivo
To understand whether the removal of carbohydrate moieties from CII specific IgG mAbs affected their capacity to bind joint cartilage in vivo, we injected mAb into neonatal DA rats. Paw samples collected 24 hours after mAb injection were sectioned and stained with anti-kappa antibodies. There was no difference in the binding pattern of EndoS treated and untreated antibodies to the joint cartilage in vivo demonstrating that the removal of carbohydrates by EndoS did not affect antigen binding capacity of the mAb (Fig 2) . Similarly, we did not find any difference in the sera levels of these injected antibodies i.e. clearance of normal and EndoS treated antibodies in vivo (data not shown). ARGLT)] induced an acute arthritis in mice (CAIA) that resembles effector phase of arthritis [39] . To understand whether the removal of carbohydrate side chains affect the arthritis inducing capacity of pathogenic mAbs, we injected a cocktail of mAbs treated or untreated with EndoS. As shown in the Fig. 3 , there was a profound inhibition of clinical arthritis in (BALB/c X B10.Q) F1 and B10.RIII mice that received EndoS treated antibodies. These strains of mice were earlier shown to be highly susceptible for CAIA [32] . There was a massive infiltration of cells as well as cartilage and bone erosion in the joints from mice injected with normally glycosylated antibodies. In contrast, mouse paws showed only minor bone erosion and no significant cell infiltration after the transfer of Endo S treated mAbs. Joint articular cartilage from these mice looked normal (Fig. 3) . Thus, these results clearly indicate that the removal of the N-linked glycan of IgGs by EndoS abrogates their arthritis inducing capacity in two different genetic backgrounds and as demonstrated earlier less arthritogenic capacity of the EndoS-treated antibodies was not due to the inability of these antibodies binding to the target antigen.
Arthritogenicity of anti-CII mAbs is abrogated by endoglycosidase treatment
EndoS-treated mAbs bind C1q and activate complement
The IgG heterosaccharides are known to be involved not only in the stabilization of Fc region binding sites for Clq [19, 40] but also in the structural properties of the Fc region [41] . Therefore, we tested in vitro, whether the removal of carbohydrate from γ-chains of IgG by EndoS reduced or abolished the ability of mAbs to activate complement (Fig. 4) . We found that there was no difference in the first complement component C1q deposition on mAbs +/-EndoS treatment bound to CII (Fig.4A) or coated directly to plastic surface (Fig.4B) . Similarly, there was no difference between treated and non-treated antibodies with regard to deposition of C3b (Fig 4C   and D) . Interestingly, CIIC1 mAb (+/-EndoS treatment) bound negligible amounts of C1q and did not cause any activation of complement as has been previously reported [34] . However, when the antibodies were directly coated on plates, CIIC1 was able to bind C1q and cause deposition of C3b.
EndoS-treated antibodies bind less efficiently to Fcγ receptors
Since, there was no difference in the complement activation as well as in the ability to bind antigens between fully glycosylated and EndoS-treated antibodies, we next asked the question; why the removal of carbohydrate from γ-chains of IgG reduced/abolished the clinical arthritis? Using SPR (Biacore) kinetic analysis, we found that EndoS-treated antibodies have lower affinity to recombinant FcγI, FcγIIb, FcγIII and FcγIV proteins ( Fig. 5 and Table 1 ). These findings provide one possible explanation for the loss of arthritogenicity of treated EndoS-treated mAbs because arthritis in CAIA involves FcγR systems apart from activation of complement components.
IgG glycosylation status affects stable immune complex formation
It is most likely that an early step in the initial triggering event in the CAIA model is the binding of the antibodies to CII in the cartilage matrix and the formation of collagen-IgG immune complexes [42, 43] . The CII epitopes recognized by antibodies are located in a repetitive structure formed by CII molecules within the matrix and on the surface of the cartilage [42, 44] Interestingly, elevated levels of agalactosyl glycoforms were found in female RA patients, while decreased levels were correlated with disease remission during gestation followed by postpartum recurrence [50] . The glycoform distribution of serum IgG was shown to change with age [51, 52] [61] . Furthermore, removal of the complete carbohydrate moiety abolished ability to activate complement and ADCC of a human IgG1 mAb, Campath-1H, but left antigen and protein A binding activity intact, whereas removal of terminal sialic acid residues through glycopeptidase-F digestion did not affect any of the tested IgG activities. [13] . Moreover, sialylated IgG autoantibodies remained poorly pathogenic because of the limited Fc-associated effector functions and loss of cryoglobulin activity [62, 63] . These contradictory observations might be explained by the length and nature of residual carbohydrate structures that remained after cleavage from IgG molecule.
Furthermore, we found no difference in the C1q and C3b deposition on mAbs (+/-EndoS treatment) bound to CII or plastic surface. Interestingly, CII bound CIIC1 (both Endo S treated and untreated) mAb initiated negligible amounts of C1q binding and also did not cause any complement activation as measured by C3b deposition. However, when the antibodies were directly coated on plates, CIIC1 was able to bind C1q and cause deposition of C3b implying that it is the orientation of these antibodies when bound to collagen that precludes binding of C1q and activation of complement. We observed similar phenomenon with different mAbs directed against C1 III but not other CII epitopes (data not shown).
Thus, it will be interesting to further analyze the carbohydrate structure-function relationship of IgG molecules using recombinant EndoS for future analytic and therapeutic applications in autoimmune diseases.
Materials and Methods
Animals
The founders of our B10.Q and B10.RIII mice originate from Professor Jan Klein 
Purification of CII specific mAbs
The CII specific hybridomas were generated and characterized as described in detail elsewhere [64, 65] . The anti-CII antibody producing hybridomas, M2139 and CIIC1
were cultured in ultra low bovine IgG containing DMEM Glutamax-I culture medium (Gibco BRL, Invitrogen AB, Sweden) with 100 mg/l of Kanamycin monosulfate (Sigma, St. Louis, USA). MAbs were generated in large scale as culture supernatant using integra cell line 1000 (CL-1000) flasks (Integra Biosciences, Switzerland). Antibodies were purified using γ-bind plus affinity gel matrix (GE Healthcare, Sweden) and Äkta purification system (GE Healthcare, Sweden).
Briefly, culture supernatants were centrifuged at 12500 rpm for 30 min, filtered and degassed before applying to the gel matrix. The gel was washed extensively and the antibodies were eluted using acetic acid buffer at pH 3.0 and neutralized with 1 M Tris-HCl, pH 9.0. The peak fractions were pooled and dialyzed extensively against PBS, pH 7.0 with or without azide. The IgG content was determined by freezedrying. The antibody solutions were filter sterilized using 0.2 µm syringe filters (Dynagard, Spectrum Laboratories, CA, USA), aliquoted and stored at -70°C until used. Amount of endotoxin content in the antibody solutions prepared was found to be negligible and the antibodies induced arthritis in the TLR-4-deficient (LPS nonresponder) mice [32] .
EndoS-treatment of mAbs
MAbs C1 and M2139 were hydrolyzed with recombinant EndoS fused to GST (GST-EndoS) purified as previously described [66] Enzyme/substrate molar ratio was 1:400 in PBS and samples were incubated for 24h at 37°C. GST-EndoS was removed from the samples by passing three times over a glutathione-Sepharose column (Amersham Biosciences, Uppsala, Sweden). One µg of treated and untreated IgG was separated by 10% SDS-PAGE followed by staining with Coomassie Blue.
For lectin blot analysis, 100 ng of IgG was separated as above and blotted to
Immobilon-P PVDF-membrane (Millipore, Bedford, MA). Membranes were blocked with 10 mM HEPES (pH 7.5) with 0.15 M NaCl, 0.01 mM MnCl 2 , 0.1 mM CaCl 2 , and 0.1% Tween-20 (HBST) and incubated with 1 µg/ml of biotinylated Lens culinaris agglutinin (LCA) lectin (Vector Laboratories, Burlingame, CA). After washing in HBST, membranes were incubated with 50 ng/ml of peroxidase-labeled streptavidin (Vector Laboratories). After washing, membranes were developed using Super Signal West Pico Chemiluminiscent Substrate (Pierce, Rockford, IL) and developed using a ChemiDoc XRS imaging system (BioRad, Hecules, CA).
Complement assays
All incubation steps were made with 50 µl solution for 1 h and in room temperature except when stated otherwise. Every step was followed by extensive washing with 50 mM Tris-HCl, 150 mM NaCl, 0.1 % Tween; pH 7.5. Microtiter plates (Maxisorp, Nunc, Roskilde, Denmark) were coated over night at 4°C with either CII (10 µg/ml) or directly with the mAbs diluted in 75 mM Na-carbonate, pH 9.6. The wells were blocked for 2 h with 200 ml of 3 % fish gelatine in washing buffer (blocking buffer).
The plates coated with CII were incubated for with 10 µg/ml of each antibody were then allowed to bind (both diluted 1:1000 in the blocking buffer). Bound enzyme was assayed using 1,2-phenylenediamine dihydrochloride (OPD) -tablets (Dako) and absorbance was measured at 490 nm.
Surface plasmon resonance (SPR) analysis
SPR analysis was performed as described earlier [67] . 
Collagen antibody induced arthritis (CAIA)
The two arthritogenic mAbs combination described earlier [32] 
Clinical evaluation of arthritis
Mice were examined daily for the arthritis development for a minimum of 21 days or until the inflammation subsided. Scoring of animals was done blindly using a scoring system based on the number of inflamed joints in each paw, inflammation being defined by swelling and redness as described previously [68] . Scoring was recorded in the phalangeal joints (maximum of 1 point per digit, 5 points per paw), the metacarpus or metatarsus (5 points), and in the wrist and ankle joints (5 points).
Thus, the maximum score was 15/paw resulting in a peak of 60 for the total joint count.
Histological Preparations
Paws were dissected on the indicated day from each group of mice (3-4 mice per group), fixed in 4% phosphate buffered paraformaldehyde solution (pH 7.0) for 24 hours, decalcified for 3-4 weeks in an solution containing EDTA, polyvinylpyrrolidone and Tris-HCl, pH 6.95 followed by dehydration and embedding in paraffin. Sections of 6 µm were stained with hematoxylin-eosin to determine cellular infiltration and bone and cartilage morphology. For immunohistochemistry, paws were immediately frozen in OCT compound using isopentane on dry ice. The samples were stored at -70°C until cryosectioned at 10 µm at -30°C. Biotinylated rat anti-mouse Igκ mAb (clone 187.1), streptavidin peroxidase and diaminobenzidine were used for detection of cartilage bound anti-CII antibodies.
Statistical analyses
All the mice were included for calculation of arthritis susceptibility and severity. The severity of arthritis was analyzed by Mann Whitney U test and the incidence by Chi 
